Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
DOI: | 10.3109/07435800.2016.1173056 |
Texto Completo: | http://dx.doi.org/10.3109/07435800.2016.1173056 http://hdl.handle.net/11449/172913 |
Resumo: | Background: Stimulated thyroglobulin (STg) levels in patients with differentiated thyroid carcinomas (DTCs) after total thyroidectomy (TT) and before radioactive iodine (131I) ablation/therapy (RIT) are predictive of therapeutic success but can be influenced by the thyroid-stimulating hormone (TSH) level. Objectives: This study compared the reliability of the STg/TSH ratio and STg measurement in predicting the success of RIT. Methods: Sixty-three DTC patients submitted to TT were assessed retrospectively to compare the ability of STg level and the STg/TSH ratio to predict successful RIT. Results: In this study 48 (76.2%) patients had successful RIT. The successful and unsuccessful groups received different 131I doses and had different STg levels and STg/TSH ratios. The STg and STg/TSH ratio cutoff values that predicted successful RIT were 4.41 ng/mL (sensitivity of 86.7% and specificity of 77%) and 0.093 (sensitivity of 80% and specificity of 79.2%), respectively. Age, STg level, STg/TSH ratio, and 131I dose were associated with successful RIT, but after multivariate analysis only STg remained associated (p < 0.05). Conclusion: In conclusion, our data suggest that the STg/TSH ratio and measurement of STg are equally reliable in predicting successful RIT in DTC patients. |
id |
UNSP_1b2ecc6233ae4c9b0fed14bddfb985a1 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/172913 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancersBiological markersprognosisthyroglobulinthyroid neoplasmsthyrotropinBackground: Stimulated thyroglobulin (STg) levels in patients with differentiated thyroid carcinomas (DTCs) after total thyroidectomy (TT) and before radioactive iodine (131I) ablation/therapy (RIT) are predictive of therapeutic success but can be influenced by the thyroid-stimulating hormone (TSH) level. Objectives: This study compared the reliability of the STg/TSH ratio and STg measurement in predicting the success of RIT. Methods: Sixty-three DTC patients submitted to TT were assessed retrospectively to compare the ability of STg level and the STg/TSH ratio to predict successful RIT. Results: In this study 48 (76.2%) patients had successful RIT. The successful and unsuccessful groups received different 131I doses and had different STg levels and STg/TSH ratios. The STg and STg/TSH ratio cutoff values that predicted successful RIT were 4.41 ng/mL (sensitivity of 86.7% and specificity of 77%) and 0.093 (sensitivity of 80% and specificity of 79.2%), respectively. Age, STg level, STg/TSH ratio, and 131I dose were associated with successful RIT, but after multivariate analysis only STg remained associated (p < 0.05). Conclusion: In conclusion, our data suggest that the STg/TSH ratio and measurement of STg are equally reliable in predicting successful RIT in DTC patients.Internal Medicine Department Botucatu Medical School São Paulo State University UnespOphthalmology Otorhinolaryngology and Head and Neck Surgery Department Botucatu Medical School São Paulo State University UnespPathology Department Botucatu Medical School São Paulo State University UnespTropical Diseases and Imaging Diagnosis Department Botucatu Medical School São Paulo State University UnespInternal Medicine Department Botucatu Medical School São Paulo State University UnespOphthalmology Otorhinolaryngology and Head and Neck Surgery Department Botucatu Medical School São Paulo State University UnespPathology Department Botucatu Medical School São Paulo State University UnespTropical Diseases and Imaging Diagnosis Department Botucatu Medical School São Paulo State University UnespUniversidade Estadual Paulista (Unesp)Trevizam, Paula Grasiele Carvalho [UNESP]Tagliarini, José Vicente [UNESP]Castilho, Emanuel Celice [UNESP]de Alencar Marques, Mariângela [UNESP]Kiy, Yoshio [UNESP]da Silva Mazeto, Gláucia Maria Ferreira [UNESP]2018-12-11T17:02:41Z2018-12-11T17:02:41Z2017-01-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article42-48http://dx.doi.org/10.3109/07435800.2016.1173056Endocrine Research, v. 42, n. 1, p. 42-48, 2017.1532-42060743-5800http://hdl.handle.net/11449/17291310.3109/07435800.2016.11730562-s2.0-84965022073Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEndocrine Research0,5060,506info:eu-repo/semantics/openAccess2024-09-03T13:18:43Zoai:repositorio.unesp.br:11449/172913Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T13:18:43Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers |
title |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers |
spellingShingle |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers Trevizam, Paula Grasiele Carvalho [UNESP] Biological markers prognosis thyroglobulin thyroid neoplasms thyrotropin Trevizam, Paula Grasiele Carvalho [UNESP] Biological markers prognosis thyroglobulin thyroid neoplasms thyrotropin |
title_short |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers |
title_full |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers |
title_fullStr |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers |
title_full_unstemmed |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers |
title_sort |
Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers |
author |
Trevizam, Paula Grasiele Carvalho [UNESP] |
author_facet |
Trevizam, Paula Grasiele Carvalho [UNESP] Trevizam, Paula Grasiele Carvalho [UNESP] Tagliarini, José Vicente [UNESP] Castilho, Emanuel Celice [UNESP] de Alencar Marques, Mariângela [UNESP] Kiy, Yoshio [UNESP] da Silva Mazeto, Gláucia Maria Ferreira [UNESP] Tagliarini, José Vicente [UNESP] Castilho, Emanuel Celice [UNESP] de Alencar Marques, Mariângela [UNESP] Kiy, Yoshio [UNESP] da Silva Mazeto, Gláucia Maria Ferreira [UNESP] |
author_role |
author |
author2 |
Tagliarini, José Vicente [UNESP] Castilho, Emanuel Celice [UNESP] de Alencar Marques, Mariângela [UNESP] Kiy, Yoshio [UNESP] da Silva Mazeto, Gláucia Maria Ferreira [UNESP] |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) |
dc.contributor.author.fl_str_mv |
Trevizam, Paula Grasiele Carvalho [UNESP] Tagliarini, José Vicente [UNESP] Castilho, Emanuel Celice [UNESP] de Alencar Marques, Mariângela [UNESP] Kiy, Yoshio [UNESP] da Silva Mazeto, Gláucia Maria Ferreira [UNESP] |
dc.subject.por.fl_str_mv |
Biological markers prognosis thyroglobulin thyroid neoplasms thyrotropin |
topic |
Biological markers prognosis thyroglobulin thyroid neoplasms thyrotropin |
description |
Background: Stimulated thyroglobulin (STg) levels in patients with differentiated thyroid carcinomas (DTCs) after total thyroidectomy (TT) and before radioactive iodine (131I) ablation/therapy (RIT) are predictive of therapeutic success but can be influenced by the thyroid-stimulating hormone (TSH) level. Objectives: This study compared the reliability of the STg/TSH ratio and STg measurement in predicting the success of RIT. Methods: Sixty-three DTC patients submitted to TT were assessed retrospectively to compare the ability of STg level and the STg/TSH ratio to predict successful RIT. Results: In this study 48 (76.2%) patients had successful RIT. The successful and unsuccessful groups received different 131I doses and had different STg levels and STg/TSH ratios. The STg and STg/TSH ratio cutoff values that predicted successful RIT were 4.41 ng/mL (sensitivity of 86.7% and specificity of 77%) and 0.093 (sensitivity of 80% and specificity of 79.2%), respectively. Age, STg level, STg/TSH ratio, and 131I dose were associated with successful RIT, but after multivariate analysis only STg remained associated (p < 0.05). Conclusion: In conclusion, our data suggest that the STg/TSH ratio and measurement of STg are equally reliable in predicting successful RIT in DTC patients. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-01-02 2018-12-11T17:02:41Z 2018-12-11T17:02:41Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3109/07435800.2016.1173056 Endocrine Research, v. 42, n. 1, p. 42-48, 2017. 1532-4206 0743-5800 http://hdl.handle.net/11449/172913 10.3109/07435800.2016.1173056 2-s2.0-84965022073 |
url |
http://dx.doi.org/10.3109/07435800.2016.1173056 http://hdl.handle.net/11449/172913 |
identifier_str_mv |
Endocrine Research, v. 42, n. 1, p. 42-48, 2017. 1532-4206 0743-5800 10.3109/07435800.2016.1173056 2-s2.0-84965022073 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Endocrine Research 0,506 0,506 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
42-48 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1822183552480968704 |
dc.identifier.doi.none.fl_str_mv |
10.3109/07435800.2016.1173056 |